(Q43040796)

12 November 2017

title

Dysregulation of renal vitamin D metabolism in the uremic rat. (English)

1 reference

12 November 2017

0 references

Christian F Helvig

1

1 reference

12 November 2017

Dominic Cuerrier

2

1 reference

12 November 2017

Christopher M Hosfield

3

1 reference

12 November 2017

Breanna Ireland

4

1 reference

12 November 2017

Aza Z Kharebov

5

1 reference

12 November 2017

Jae W Kim

6

1 reference

12 November 2017

Navindra J Ramjit

7

1 reference

12 November 2017

Kara Ryder

8

1 reference

12 November 2017

Samir P Tabash

9

1 reference

12 November 2017

Andrew M Herzenberg

10

1 reference

12 November 2017

Tina M Epps

11

1 reference

12 November 2017

Martin Petkovich

12

1 reference

12 November 2017

language of work or name

English

0 references

publication date

9 June 2010

1 reference

12 November 2017

1 reference

12 November 2017

volume

78

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

463-472

1 reference

Overview of general physiologic features and functions of vitamin D.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Vitamin D for health and in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Vitamin D and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Hypertension and kidney disease: a deadly connection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Obesity, insulin resistance and kidney disease risk: insights into the relationship

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Overweight, obesity and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Localization of 25-hydroxyvitamin D3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Nonclassic actions of vitamin D

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Vitamin D and tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Vitamin D and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Association of activated vitamin D treatment and mortality in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Association of oral calcitriol with improved survival in non-dialysed and dialysed patients with CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Renal 25-hydroxyvitamin D3-1-hydroxylase in patients with renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase. A study with the mature enzyme expressed in Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Quantitative immunoelectron microscopic analysis of the localization and induction of 25-hydroxyvitamin D3 24-hydroxylase in rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

X-linked hypophosphatemia. A phenotype in search of a cause

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Increased renal 25-hydroxyvitamin D3-24-hydroxylase messenger ribonucleic acid and immunoreactive protein in phosphate-deprived Hyp mice: a mechanism for accelerated 1,25-dihydroxyvitamin D3 catabolism in X-linked hypophosphatemic rickets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Early lethality in Hyp mice with targeted deletion of Pth gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Expression of VDR and CYP24A1 mRNA in human tumors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

CYP27A1 and CYP24 expression as a function of malignant transformation in the colon.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Evidence for abnormal translational regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase activity in the hyp-mouse

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.168

7 January 2021

Identifiers

DOI

10.1038/KI.2010.168

1 reference

12 November 2017

1 reference